Zenotech Laboratories Ltd.
| BSE: 532039 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE486F01012 |
| BSE 00:00 | 26 Nov | 42.90 |
-2.00 (-4.45%) |
OPEN
46.90 |
HIGH
46.90 |
LOW
42.00 |
| NSE 05:30 | 01 Jan | Zenotech Laboratories Ltd |
| OPEN | 46.90 |
| PREVIOUS CLOSE | 44.90 |
| VOLUME | 10125 |
| 52-Week high | 62.65 |
| 52-Week low | 26.20 |
| P/E | 46.13 |
| Mkt Cap.(Rs cr) | 262 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Zenotech Laboratories Ltd. (ZENOTECHLAB) - News Sector
-
BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%
1.59 pm | 26 Nov 2021 | Business Standard
The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.
-
BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%
1.59 pm | 26 Nov 2021 | Business Standard
The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.
-
BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%
1.59 pm | 26 Nov 2021 | Business Standard
The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.
-
BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%
1.59 pm | 26 Nov 2021 | Business Standard
The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.
-
BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%
1.59 pm | 26 Nov 2021 | Business Standard
The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.
-
BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%
1.59 pm | 26 Nov 2021 | Business Standard
The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.
-
Here's why Mehul Kothari recommends buying Hikal, Jindal Saw
8.01 am | 26 Nov 2021 | Business Standard
According to the technical analyst from Anand Rathi, JINDALSAW has seen a strong resurgence in the last two sessions backed by robust volumes indicati...
-
Zydus Cadila likely to launch Covid-19 vaccine ZyCoV-D next month
12.13 am | 26 Nov 2021 | Business Standard
Meanwhile, Zydus is working with a Korean partner to commercialise ZyCoV-D in South Korea in 2022
-
GSK Pharma surges 11%, hits 52-week high on improved outlook
12.20 pm | 25 Nov 2021 | Business Standard
The management expects this positive momentum to continue through the second half of the year driving the company towards the better end of a meaningf...
-
Ipca Labs' board approves acquisition of over 26% stake in Lyka Labs
2.58 pm | 24 Nov 2021 | Business Standard
Lyka Labs is engaged in the manufacturing and marketing of injectables, lyophilized injectables and topical formulations
-
Raymond, ONGC, IOB: 5 stocks which should not be ignored today
11.36 am | 24 Nov 2021 | Business Standard
Shares of Raymond Ltd and IOB are showing extreme bullish outlook on the charts
-
Here's why Subash Gangadharan is bullish on Hikal, Gujarat Gas
7.55 am | 24 Nov 2021 | Business Standard
The technical & derivative analyst from HDFC Securities expects weakness in Nifty to continue
-
Lyka Labs hits 5% upper circuit after Ipca buys 1 mn shares via bulk deals
12.12 pm | 23 Nov 2021 | Business Standard
On Monday, Ipca Laboratories purchased 1.05 million equity shares representing 3.65 per cent stake in Lyka Labs at price of Rs 123 per share on the BS...
-
Lyka Labs hits 5% upper circuit after Ipca buys 1 mn shares via bulk deals
12.12 pm | 23 Nov 2021 | Business Standard
On Monday, Ipca Laboratories purchased 1.05 million equity shares representing 3.65 per cent stake in Lyka Labs at price of Rs 123 per share on the BS...
-
Set to zoom: Maruti, Tech M among 5 Nifty stocks that can gain up to 14%
12.10 pm | 23 Nov 2021 | Business Standard
The sharp fall in the market has seen these stocks slip into oversold zone. Charts hint at a sharp rally in all these from the current levels, provide...
-
Stocks to Watch: DLF, Airtel, Vedanta, Cadila, Escorts, Voda Idea, Zen Tech
8.31 am | 23 Nov 2021 | Business Standard
The SGX Nifty indicates a quiet start for our markets this morning
-
HCG acquires majority stake in Suchirayu
10.00 pm | 22 Nov 2021 | Business Standard
Suchirayu owns a multi-speciality hospital in Hubli with an operational capacity of 110 beds
-
Hero MotoCorp, Lupin, Colgate, Aurobindo, Amara Raja hit 52-week lows
3.11 pm | 22 Nov 2021 | Business Standard
In past four trading days, the S&P BSE Sensex has tanked 4 per cent or 2,412 points on concerns about European Covid-19 curbs and on risk of the US Fe...
-
Hero MotoCorp, Lupin, Colgate, Aurobindo, Amara Raja hit 52-week lows
3.11 pm | 22 Nov 2021 | Business Standard
In past four trading days, the S&P BSE Sensex has tanked 4 per cent or 2,412 points on concerns about European Covid-19 curbs and on risk of the US Fe...
-
Piramal OTC aims to double turnover to Rs 1,000 cr in three years
1.47 am | 19 Nov 2021 | Business Standard
PEL's Pharma and financial services arms demerger is expected to be completed over next 3 quarters
Quick Links for Zenotech Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
